FRAX486 is primarily used in research settings to study its effects on cellular processes, particularly in the context of cancer biology. It is known to inhibit specific kinases involved in signaling pathways that regulate cell growth and survival. By targeting these pathways, FRAX486 helps researchers understand the mechanisms of tumor progression and explore potential therapeutic strategies. Its application is valuable in preclinical studies aimed at developing treatments for cancers driven by dysregulated kinase activity. Additionally, it serves as a tool to investigate the role of these pathways in other diseases where cellular signaling is disrupted.